P2RX7 and neoplasm: However, subsequent identification of P2X7 receptor variants, with more precise characterization of the responses and measurement of cancer cell expression levels, indicated this subtype was upregulated in many tumor types (McLarnon, 2017; Di Virgilio et al., 2018, Zhang et al., 2019a; 2019b).